Unknown

Dataset Information

0

HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation.


ABSTRACT: Activated oncogenes are the dominant drivers of malignant progression in human cancer, yet little is known about how the transformation from proto-oncogene to activated oncogene drives the expression of transformed phenotypes. An isogenic model of HER-2-mediated transformation of human mammary epithelial cells was used along with HER-2-amplified human breast cancers to investigate how HER-2 activation alters its properties as a signaling molecule and changes the networks of HER-2-regulated genes. Our results show that full oncogenic activation of HER-2 is the result of a transition in which activated HER-2 acquires dominant signaling properties that qualitatively alter the network of genes regulated by the activated oncogene compared with the proto-oncogene. Consequently, gene expression programs related to invasion, cell stress, and stemness become regulated by HER-2 in a manner not observed in nontransformed cells, even when HER-2 is overexpressed. Our results offer novel insights into biological processes that come under the control of HER-2 after it acquires full oncogenic potential.

SUBMITTER: Bollig-Fischer A 

PROVIDER: S-EPMC3858175 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation.

Bollig-Fischer Aliccia A   Dziubinski Michele M   Boyer Alaina A   Haddad Ramsi R   Giroux Craig N CN   Ethier Stephen P SP  

Cancer research 20100824 20


Activated oncogenes are the dominant drivers of malignant progression in human cancer, yet little is known about how the transformation from proto-oncogene to activated oncogene drives the expression of transformed phenotypes. An isogenic model of HER-2-mediated transformation of human mammary epithelial cells was used along with HER-2-amplified human breast cancers to investigate how HER-2 activation alters its properties as a signaling molecule and changes the networks of HER-2-regulated genes  ...[more]

Similar Datasets

2010-08-24 | E-GEOD-23175 | biostudies-arrayexpress
2010-08-24 | GSE23175 | GEO
| S-EPMC7220922 | biostudies-literature
| S-EPMC2919174 | biostudies-literature
| S-EPMC2830489 | biostudies-literature
| S-EPMC2637204 | biostudies-literature
| S-EPMC4710793 | biostudies-literature
| S-EPMC2376225 | biostudies-literature
| S-EPMC6172782 | biostudies-literature
| S-EPMC4011847 | biostudies-literature